Vial

FEBRUARY 15, 2024

Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1.

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

H1 Blog

JULY 30, 2024

This sets the stage for binding and enforceable components per Section 3601 of the Food and Drug Omnibus Reform Act (FDORA), which will come into effect 180 days after the final guidance is published. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

DrugBank

JUNE 27, 2024

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 72

Drugs Pharma Companies Clinical Trials Computational Chemistry 72

The Connected Lab

APRIL 8, 2020

If we think about research in more traditional areas such as oncology, gastroenterology, and CNS disorders where large amounts of data have already been produced, AI, ML, and DL can help discover new compounds that could become new drugs, uncover or repurpose drugs, and improve the area of personalized medicine. Nature , vol.

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52